Fibroblasts derived from human embryonic stem cells direct development and repair of 3D human skin equivalents

Yulia Shamis, Kyle J. Hewitt, Mark W. Carlson, Mariam Margvelashvilli, Shumin Dong, Catherine K. Kuo, Laurence Daheron, Christophe Egles, Jonathan A. Garlick

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

Introduction. Pluripotent, human stem cells hold tremendous promise as a source of progenitor and terminally differentiated cells for application in future regenerative therapies. However, such therapies will be dependent upon the development of novel approaches that can best assess tissue outcomes of pluripotent stem cell-derived cells and will be essential to better predict their safety and stability following in vivo transplantation. Methods. In this study we used engineered, human skin equivalents (HSEs) as a platform to characterize fibroblasts that have been derived from human embryonic stem (hES) cell. We characterized the phenotype and the secretion profile of two distinct hES-derived cell lines with properties of mesenchymal cells (EDK and H9-MSC) and compared their biological potential upon induction of differentiation to bone and fat and following their incorporation into the stromal compartment of engineered, HSEs. Results: While both EDK and H9-MSC cell lines exhibited similar morphology and mesenchymal cell marker expression, they demonstrated distinct functional properties when incorporated into the stromal compartment of HSEs. EDK cells displayed characteristics of dermal fibroblasts that could support epithelial tissue development and enable re-epithelialization of wounds generated using a 3D tissue model of cutaneous wound healing, which was linked to elevated production of hepatocyte growth factor (HGF). Lentiviral shRNA-mediated knockdown of HGF resulted in a dramatic decrease of HGF secretion from EDK cells that led to a marked reduction in their ability to promote keratinocyte proliferation and re-epithelialization of cutaneous wounds. In contrast, H9-MSCs demonstrated features of mesenchymal stem cells (MSC) but not those of dermal fibroblasts, as they underwent multilineage differentiation in monolayer culture, but were unable to support epithelial tissue development and repair and produced significantly lower levels of HGF. Conclusions: Our findings demonstrate that hES-derived cells could be directed to specified and alternative mesenchymal cell fates whose function could be distinguished in engineered HSEs. Characterization of hES-derived mesenchymal cells in 3D, engineered HSEs demonstrates the utility of this tissue platform to predict the functional properties of hES-derived fibroblasts before their therapeutic transplantation.

Original languageEnglish (US)
Article number10
JournalStem Cell Research and Therapy
Volume2
Issue number1
DOIs
StatePublished - 2011

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Molecular Medicine
  • Biochemistry, Genetics and Molecular Biology (miscellaneous)
  • Cell Biology

Fingerprint Dive into the research topics of 'Fibroblasts derived from human embryonic stem cells direct development and repair of 3D human skin equivalents'. Together they form a unique fingerprint.

  • Cite this

    Shamis, Y., Hewitt, K. J., Carlson, M. W., Margvelashvilli, M., Dong, S., Kuo, C. K., Daheron, L., Egles, C., & Garlick, J. A. (2011). Fibroblasts derived from human embryonic stem cells direct development and repair of 3D human skin equivalents. Stem Cell Research and Therapy, 2(1), [10]. https://doi.org/10.1186/scrt51